High GALNT10 expression confers an immunosuppressive microenvironment, promotes tumor progression, predicts poor clinical outcomes in high-grade ovarian serous cancer (HGSC; Zhang G. et al., 2020) and promotes proliferation and apoptosis resistance of hepatoma cells (Wu et al., 2015). This evidence concerns the gene GALNT10 and neoplasm.